Commodore Capital Lp Top Holdings and 13F Report (2024) About Commodore Capital LpInvestment ActivityCommodore Capital Lp has $1.36 billion in total holdings as of June 30, 2024.Commodore Capital Lp owns shares of 31 different stocks, but just 14 companies or ETFs make up 80% of its holdings.Approximately 21.53% of the portfolio was purchased this quarter.About 5.27% of the portfolio was sold this quarter.This quarter, Commodore Capital Lp has purchased 31 new stocks and bought additional shares in 13 stocks.Commodore Capital Lp sold shares of 4 stocks and completely divested from 4 stocks this quarter.Largest Holdings Merus $188,261,836Nuvalent $131,556,600Enliven Therapeutics $92,004,000Soleno Therapeutics $82,167,500Xenon Pharmaceuticals $78,003,750 Largest New Holdings this Quarter 00847X104 - Agios Pharmaceuticals $64,020,500 Holding15117B202 - Celldex Therapeutics $58,080,000 Holding83422E204 - Solid Biosciences $21,552,500 Holding90240B106 - Tyra Biosciences $8,835,000 Holding Largest Purchases this Quarter Agios Pharmaceuticals 2,185,000 shares (about $64.02M)Celldex Therapeutics 3,200,000 shares (about $58.08M)Scholar Rock 795,000 shares (about $25.56M)Merus 598,658 shares (about $25.20M)Solid Biosciences 5,825,000 shares (about $21.55M) Largest Sales this Quarter Soleno Therapeutics 375,000 shares (about $26.79M)Xenon Pharmaceuticals 415,000 shares (about $13.92M)Alkermes 350,000 shares (about $11.56M)Inhibikase Therapeutics 580,568 shares (about $1.27M) Sector Allocation Over TimeMap of 500 Largest Holdings ofCommodore Capital Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorMRUSMerus$188,261,836$25,197,515 ▲15.5%4,472,84013.9%MedicalNUVLNuvalent$131,556,600$16,552,728 ▲14.4%1,855,0009.7%MedicalELVNEnliven Therapeutics$92,004,000$9,249,600 ▲11.2%4,675,0006.8%MedicalSLNOSoleno Therapeutics$82,167,500$26,793,750 ▼-24.6%1,150,0006.1%MedicalXENEXenon Pharmaceuticals$78,003,750$13,923,250 ▼-15.1%2,325,0005.7%MedicalALKSAlkermes$64,389,000$11,557,000 ▼-15.2%1,950,0004.7%MedicalAGIOAgios Pharmaceuticals$64,020,500$64,020,500 ▲New Holding2,185,0004.7%MedicalPCVXVaxcyte$62,304,000$944,000 ▲1.5%1,650,0004.6%MedicalVERAVera Therapeutics$61,534,004$14,488,432 ▲30.8%2,561,7824.5%MedicalCLDXCelldex Therapeutics$58,080,000$58,080,000 ▲New Holding3,200,0004.3%MedicalSRRKScholar Rock$56,101,750$25,559,250 ▲83.7%1,745,0004.1%MedicalCOGTCogent Biosciences$53,267,968$12,047,010 ▲29.2%8,892,8163.9%MedicalVRDNViridian Therapeutics$48,528,000$16,176,000 ▲50.0%3,600,0003.6%MedicalNRIXNurix Therapeutics$47,269,415$11,629,415 ▲32.6%3,978,9073.5%MedicalCNTACentessa Pharmaceuticals$34,045,772$2,144,820 ▲6.7%2,367,5782.5%MedicalSPYRE THERAPEUTICS INC$32,077,7350.0%1,988,0842.4%COM NEWPHVSPharvaris$30,009,4980.0%1,911,4332.2%MedicalMNMDMind Medicine (MindMed)$26,471,250$1,266,964 ▲5.0%4,525,0002.0%MedicalSLDBSolid Biosciences$21,552,500$21,552,500 ▲New Holding5,825,0001.6%MedicalBRIGHT MINDS BIOSCIENCES INC$18,035,0000.0%500,0001.3%COM NEWCRDFCardiff Oncology$16,907,6940.0%5,384,6161.2%MedicalORUKA THERAPEUTICS INC$14,566,2660.0%1,419,7141.1%COMIKTInhibikase Therapeutics$11,704,306$1,271,444 ▼-9.8%5,344,4320.9%MedicalORICORIC Pharmaceuticals$11,160,0000.0%2,000,0000.8%MedicalAPOGEE THERAPEUTICS INC$10,834,4000.0%290,0000.8%COMNEUROGENE INC$10,831,750$1,463,750 ▲15.6%925,0000.8%COMTYRATyra Biosciences$8,835,000$8,835,000 ▲New Holding950,0000.7%MedicalPERCEPTIVE CAP SOLUTIONS COR$7,725,0000.0%750,0000.6%CL A ORD SHSCELCCelcuity$7,033,022$2,989,022 ▲73.9%695,6500.5%MedicalVTGNVistagen Therapeutics$3,937,5000.0%1,575,0000.3%MedicalAVALO THERAPEUTICS INC$3,868,8300.0%483,0000.3%COM NEWABIVAX SA$0$9,399,685 ▼-100.0%00.0%SPONSORED ADSHELIX ACQUISITION CORP II$0$5,250,000 ▼-100.0%00.0%CL A ORD SHSTHRDTF Financial$0$2,445,974 ▼-100.0%00.0%MedicalNKTXNkarta$0$876,102 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
